SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017000
Filing Date
2022-08-12
Accepted
2022-08-12 07:30:46
Documents
96
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20220630.htm   iXBRL 10-Q 3492399
2 EX-10.1 itrm-ex10_1.htm EX-10.1 487470
3 EX-10.2 itrm-ex10_2.htm EX-10.2 38822
4 EX-10.3 itrm-ex10_3.htm EX-10.3 38688
5 EX-31.1 itrm-ex31_1.htm EX-31.1 21335
6 EX-31.2 itrm-ex31_2.htm EX-31.2 21689
7 EX-32.1 itrm-ex32_1.htm EX-32.1 12976
8 EX-32.2 itrm-ex32_2.htm EX-32.2 12968
  Complete submission text file 0000950170-22-017000.txt   14525396

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20220630_lab.xml EX-101.LAB 613919
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itrm-20220630_cal.xml EX-101.CAL 57625
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20220630.xsd EX-101.SCH 86053
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20220630_pre.xml EX-101.PRE 508498
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itrm-20220630_def.xml EX-101.DEF 352509
90 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20220630_htm.xml XML 3007558
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 221157822
SIC: 2834 Pharmaceutical Preparations